Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses (PLA) code 0249U – originally issued to Theralink ...
Ignite Proteomics, a subsidiary of IMAC Holdings (BACK), announced the completed transfer of Proprietary Laboratory Analyses, or PLA, code ...
Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., has successfully transferred the Proprietary Laboratory Analyses (PLA) code 0249U from Theralink Technologies, allowing recognition and ...
Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses ( ...
(MENAFN- GlobeNewsWire - Nasdaq) Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of ...
(RTTNews) - Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (BACK), on Wednesday announced the successful acquisition of Proprietary Laboratory Analysis or PLA code 0249U, initially ...
Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), announces the publication of a significant study in the British Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback